Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ursula Vehling-Kaiser Susanna Hegewisch-Becker Ludwig Fischer von Weikersthal |
| Publication date | January 1, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |